483 related articles for article (PubMed ID: 23843195)
21. The gene expression profile of matrix metalloproteinases and their inhibitors in children with Henoch-Schönlein purpura.
Shin JI; Song KS; Kim H; Cho NH; Kim J; Kim HS; Lee JS
Br J Dermatol; 2011 Jun; 164(6):1348-55. PubMed ID: 21410660
[TBL] [Abstract][Full Text] [Related]
22. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression.
Hofmann UB; Westphal JR; Zendman AJ; Becker JC; Ruiter DJ; van Muijen GN
J Pathol; 2000 Jul; 191(3):245-56. PubMed ID: 10878545
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinases and their inhibitors in the developing mouse brain and spinal cord: a reverse transcription quantitative polymerase chain reaction study.
Ulrich R; Gerhauser I; Seeliger F; Baumgärtner W; Alldinger S
Dev Neurosci; 2005; 27(6):408-18. PubMed ID: 16280637
[TBL] [Abstract][Full Text] [Related]
24. Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell.
Sakaida I; Hironaka K; Kimura T; Terai S; Yamasaki T; Okita K
Life Sci; 2004 Mar; 74(18):2251-63. PubMed ID: 14987950
[TBL] [Abstract][Full Text] [Related]
25. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
26. Regulation of matrix metalloproteinases (MMPS) and their inhibitors (TIMPS) during mouse peri-implantation: role of nitric oxide.
Zhang X; Wang HM; Lin HY; Liu GY; Li QL; Zhu C
Placenta; 2004 Apr; 25(4):243-52. PubMed ID: 15028415
[TBL] [Abstract][Full Text] [Related]
27. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
28. Expression of matrix metalloproteinases and their specific inhibitors in normal and different human thyroid tumor cell lines.
Baldini E; Toller M; Graziano FM; Russo FP; Pepe M; Biordi L; Marchioni E; Curcio F; Ulisse S; Ambesi-Impiombato FS; D'Armiento M
Thyroid; 2004 Nov; 14(11):881-8. PubMed ID: 15671765
[TBL] [Abstract][Full Text] [Related]
29. Temporospatial gene expression and protein localization of matrix metalloproteinases and their inhibitors during mouse molar tooth development.
Yoshiba N; Yoshiba K; Stoetzel C; Perrin-Schmitt F; Cam Y; Ruch JV; Lesot H
Dev Dyn; 2003 Sep; 228(1):105-12. PubMed ID: 12950084
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of matrix metalloproteinases and tissue inhibitors and extracellular matrix remodeling in aortic regurgitant hearts.
Truter SL; Catanzaro DF; Supino PG; Gupta A; Carter J; Herrold EM; Dumlao TF; Borer JS
Cardiology; 2009; 113(3):161-8. PubMed ID: 19129699
[TBL] [Abstract][Full Text] [Related]
31. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
32. Expression of matrix metalloproteinases and their inhibitors in medulloblastomas and their prognostic relevance.
Ozen O; Krebs B; Hemmerlein B; Pekrun A; Kretzschmar H; Herms J
Clin Cancer Res; 2004 Jul; 10(14):4746-53. PubMed ID: 15269148
[TBL] [Abstract][Full Text] [Related]
33. Correlation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase expression in ileal carcinoids, lymph nodes and liver metastasis with prognosis and survival.
Voland P; Besig S; Rad R; Braun T; Baur DM; Perren A; Langer R; Höfler H; Prinz C
Neuroendocrinology; 2009; 89(1):66-78. PubMed ID: 18708724
[TBL] [Abstract][Full Text] [Related]
34. Expression of matrix metalloproteinases and their endogenous tissue inhibitors in skin lesions from patients with tuberous sclerosis.
Papakonstantinou E; Dionyssopoulos A; Aletras AJ; Pesintzaki C; Minas A; Karakiulakis G
J Am Acad Dermatol; 2004 Oct; 51(4):526-33. PubMed ID: 15389186
[TBL] [Abstract][Full Text] [Related]
35. Expression analysis of the entire MMP and TIMP gene families during mouse tissue development.
Nuttall RK; Sampieri CL; Pennington CJ; Gill SE; Schultz GA; Edwards DR
FEBS Lett; 2004 Apr; 563(1-3):129-34. PubMed ID: 15063736
[TBL] [Abstract][Full Text] [Related]
36. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
Young KA; Hennebold JD; Stouffer RL
Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
[TBL] [Abstract][Full Text] [Related]
37. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
38. Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway.
Kimata M; Ishizaki M; Tanaka H; Nagai H; Inagaki N
Allergol Int; 2006 Mar; 55(1):67-76. PubMed ID: 17075289
[TBL] [Abstract][Full Text] [Related]
39. Relationships between matrix metalloproteinases and tissue inhibitor of metalloproteinases in the wall of abdominal aortic aneurysms.
Nishimura K; Ikebuchi M; Kanaoka Y; Ohgi S; Ueta E; Nanba E; Ito H
Int Angiol; 2003 Sep; 22(3):229-38. PubMed ID: 14612849
[TBL] [Abstract][Full Text] [Related]
40. Expression of matrix metalloproiteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in hepatocellular carcinoma tissue, compared with the surrounding non-tumor tissue.
Matsunaga Y; Koda M; Murawaki Y
Res Commun Mol Pathol Pharmacol; 2004; 115-116():143-50. PubMed ID: 17564313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
